BioSpace News Archive

Press Releases

Humanetics Secures Additional Funding to Advance Development of Its Drug to Prevent Radiation Injury

December 10, 2024
·
3 min read
Press Releases

Incyte Late-Breaking Tafasitamab (Monjuvi®) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular Lymphoma

December 10, 2024
·
10 min read
Press Releases

City of Hope doctors and scientists present research on novel cancer therapies at American Society of Hematology (ASH) annual conference

December 10, 2024
·
19 min read
Press Releases

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

December 10, 2024
·
1 min read
Press Releases

AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND

December 10, 2024
·
7 min read
Press Releases

Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development

December 10, 2024
·
5 min read
Press Releases

Oncology Biosimilars Market Size to Reach USD 35.79 Billion By 2034

December 10, 2024
·
1 min read
Press Releases

Recce Pharmaceuticals Receives Approval from Indonesia’s Drug and Food Authority for Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections

December 10, 2024
·
5 min read
Press Releases

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

December 10, 2024
·
5 min read
Press Releases

Qnovia, Inc. Raises $16 Million in Series B Financing to Advance Lead Asset RespiRx™ Nicotine Inhaler as a Prescription Smoking Cessation Therapy

December 10, 2024
·
3 min read